Fundraising Fox
/People
Sign in

Timothy Perera

Founder

PhD Founder & CEO at Deuteroncology

Liège, Walloon Region, Belgium

FoundedDeuteroncology

Find your path to Timothy

Sign up to see every warm intro you have to Timothy

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Timothy. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Timothy Perera is the Founder and CEO of DeuterOncology NV, a biotech company he established in 2020 to develop DO-2, a deuterated MET kinase inhibitor for cancer treatment. He holds a Ph.D. in Cell Biology and has over 30 years of experience in oncology, along with patents, publications, and awards in the field. He previously co-founded OCTIMET Oncology NV, a spin-off of Janssen Pharmaceuticals, where he served as Chief Scientific Officer and led development of the MET/OCT-2 inhibitor OMO-1 through phase 1/2 clinical trials and raised over 12 million euros in funding.

PhD Founder & CEO at Deuteroncology

Intro paths

→

In turn, Timothy can intro founders to Deuteroncology's investors below.

Deuteroncology's investors · 1

Newton BiocapitalBrussels

Frequently asked questions

Who is Timothy Perera?
Timothy Perera is the Founder and CEO of DeuterOncology NV, a biotech company he established in 2020 to develop DO-2, a deuterated MET kinase inhibitor for cancer treatment. He holds a Ph.D. in Cell Biology and has over 30 years of experience in oncology, along with patents, publications, and awards in the field. He previously co-founded OCTIMET Oncology NV, a spin-off of Janssen Pharmaceuticals, where he served as Chief Scientific Officer and led development of the MET/OCT-2 inhibitor OMO-1 through phase 1/2 clinical trials and raised over 12 million euros in funding.
Where does Timothy Perera work?
Timothy Perera is PhD Founder & CEO of Deuteroncology.
What companies did Timothy Perera found?
Timothy Perera founded Deuteroncology.

Founder mafias

About this profile. Compiled from public sources — Deuteroncology's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights